InvestorsHub Logo
icon url

NY1972

10/16/15 9:11 AM

#1114 RE: DewDiligence #1113

J&J started phase 2a clinical trial for 4,6,8 weeks in treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. How about genotype 3 and others?